Holen Sie sich die Stockscreener-App
97.10
0.38%
-0.37
Handel nachbörslich:
96.90
-0.20
-0.21%
Schlusskurs vom Vortag:
$97.47
Offen:
$98.54
24-Stunden-Volumen:
3.00M
Relative Volume:
1.15
Marktkapitalisierung:
$12.61B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-22.90
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
-4.22%
1M Leistung:
+1.60%
6M Leistung:
+92.01%
1J Leistung:
+200.06%
1-Tages-Spanne:
$96.28
$99.82
1-Wochen-Bereich:
$96.28
$105.01
52-Wochen-Spanne:
$29.91
$112.42
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Vergleichen Sie GH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
97.10 | 12.66B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
562.39 | 211.36B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.35 | 157.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
697.10 | 55.54B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
136.90 | 38.68B | 6.95B | 1.30B | 1.15B | 4.5714 |
|
IQV
Iqvia Holdings Inc
|
222.52 | 37.71B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-09-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-28 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Will Guardant Health Inc. stock deliver better than expected guidance2025 Key Lessons & Proven Capital Preservation Tips - Улправда
Guardant Health Insider Sold Shares Worth $9,402,220, According to a Recent SEC Filing - marketscreener.com
Insider Sell: Helmy Eltoukhy Sells 90,565 Shares of Guardant Hea - GuruFocus
Analysts Are Bullish on Top Healthcare Stocks: Guardant Health (GH), Natera (NTRA) - The Globe and Mail
Insider Selling: Guardant Health (NASDAQ:GH) CEO Sells $9,402,458.30 in Stock - MarketBeat
Guardant Health (NASDAQ:GH) CTO Sells $567,122.04 in Stock - MarketBeat
Officer Freeman Acquires 808 Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health Executives Sell Shares Worth Millions - TradingView — Track All Markets
Guardant Health (NASDAQ:GH) Price Target Raised to $120.00 - MarketBeat
GH: Mizuho Maintains Outperform Rating, Raises Price Target to $120 | GH Stock News - GuruFocus
Guardant Health, Inc. $GH Holdings Boosted by Sicart Associates LLC - MarketBeat
Oncology Biotech Challenges Rival's Cancer Testing Patent - Law360
Guardant Health price target raised to $120 from $100 at BofA - Yahoo Finance
State of Wyoming Takes $567,000 Position in Guardant Health, Inc. $GH - MarketBeat
JP Morgan Maintains Guardant Health (GH) Overweight Recommendation - MSN
Guardant Health (GH) Sees Analyst Rating Update from Leerink Par - GuruFocus
Analyst JP Morgan Raises Price Target for Guardant Health (GH) | - GuruFocus
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
Guardant Health (GH) Receives Raised Price Target from Wells Far - GuruFocus
Leerink Partners maintains Guardant Health (GH) outperform recommendation - MSN
Guardant Health (GH): Reassessing Valuation After a Sharp Share Price Recovery - Yahoo Finance
Nikko Asset Management Americas Inc. Raises Stake in Guardant Health, Inc. $GH - MarketBeat
Castleark Management LLC Acquires New Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health (NASDAQ:GH) Stock Price Expected to Rise, BTIG Research Analyst Says - MarketBeat
Will Guardant Health Inc stock deliver strong dividend growthTake Profit & Step-by-Step Swing Trade Plans - moha.gov.vn
Eventide Asset Management LLC Sells 107,775 Shares of Guardant Health, Inc. $GH - MarketBeat
GeneDx and Guardant Health named as BTIG’s top picks for 2026 - Investing.com Canada
GH: Analyst Mark Massaro Raises Price Target for Guardant Health | GH Stock News - GuruFocus
Osterweis Capital Management Inc. Lowers Stock Position in Guardant Health, Inc. $GH - MarketBeat
Darya Chudova Sells 13,664 Shares of Guardant Health (NASDAQ:GH) Stock - MarketBeat
Guardant Health (NASDAQ:GH) Director Sells $131,250.00 in Stock - MarketBeat
Guardant Health announces proposed $300 million offering of convertible senior notes due 2033 - MSN
Guardant Health (GH) Jumps to New Record High on Earnings Blowout, Bullish Outlook - MSN
Citigroup Raises Price Target for GH to $135, Maintains Buy Rati - GuruFocus
Guardant Health Forms Collaboration With Trial Library to Increase US Access to Cancer Clinical Trials - marketscreener.com
HighVista Strategies LLC Has $1.47 Million Stake in Guardant Health, Inc. $GH - MarketBeat
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. - Yahoo Finance
Have Guardant Health Insiders Been Selling Stock? - simplywall.st
Guardant Health Insider Sold Shares Worth $10,505,474, According to a Recent SEC Filing - marketscreener.com
Guardant Health director Talasaz sells $10.5 million in shares By Investing.com - Investing.com South Africa
Guardant Health director Talasaz sells $10.5 million in shares - Investing.com
Insider Sell: Kumud Kalia Sells 2,000 Shares of Guardant Health Inc (GH) - GuruFocus
CEO Talasaz Sells 100,000 ($10.5M) Of Guardant Health Inc [GH] - TradingView — Track All Markets
Officer Kalia Sells 2,000 ($209.2K) Of Guardant Health Inc [GH] - TradingView — Track All Markets
Guardant Health, Inc. $GH Position Lowered by Blue Water Life Science Advisors LP - MarketBeat
Jump Financial LLC Buys New Position in Guardant Health, Inc. $GH - MarketBeat
Global ESR1 Mutated Metastatic Breast Cancer Diagnostics - openPR.com
Guardant Health and Policlinico Gemelli Launch In-House Liquid Biopsy Testing Service in Italy - pharmiweb.com
Investors Towarzystwo Funduszy Inwestycyjnych Spolka Akcyjna Purchases New Holdings in Guardant Health, Inc. $GH - MarketBeat
Hood River Capital Management LLC Has $12.79 Million Stock Holdings in Guardant Health, Inc. $GH - MarketBeat
Italian hospital launches on-site liquid biopsy testing with Guardant Health - Investing.com Canada
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.73%
1.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):